JP2005516044A5 - - Google Patents

Download PDF

Info

Publication number
JP2005516044A5
JP2005516044A5 JP2003563468A JP2003563468A JP2005516044A5 JP 2005516044 A5 JP2005516044 A5 JP 2005516044A5 JP 2003563468 A JP2003563468 A JP 2003563468A JP 2003563468 A JP2003563468 A JP 2003563468A JP 2005516044 A5 JP2005516044 A5 JP 2005516044A5
Authority
JP
Japan
Prior art keywords
monoclonal antibody
composition
medicament
staphylococcal
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003563468A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005516044A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/040925 external-priority patent/WO2003063772A2/en
Publication of JP2005516044A publication Critical patent/JP2005516044A/ja
Publication of JP2005516044A5 publication Critical patent/JP2005516044A5/ja
Pending legal-status Critical Current

Links

JP2003563468A 2001-12-21 2002-12-23 モノクローナル抗体の鼻内投与によるブドウ球菌の鼻コロニー形成を阻止又は緩和する方法 Pending JP2005516044A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34180601P 2001-12-21 2001-12-21
PCT/US2002/040925 WO2003063772A2 (en) 2001-12-21 2002-12-23 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies

Publications (2)

Publication Number Publication Date
JP2005516044A JP2005516044A (ja) 2005-06-02
JP2005516044A5 true JP2005516044A5 (https=) 2006-03-02

Family

ID=27662943

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003563468A Pending JP2005516044A (ja) 2001-12-21 2002-12-23 モノクローナル抗体の鼻内投与によるブドウ球菌の鼻コロニー形成を阻止又は緩和する方法

Country Status (5)

Country Link
US (1) US20030224000A1 (https=)
EP (1) EP1465926A4 (https=)
JP (1) JP2005516044A (https=)
CA (1) CA2469571A1 (https=)
WO (1) WO2003063772A2 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169903B2 (en) * 2001-12-21 2007-01-30 Biosynexus Incorporated Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
US20050050659A1 (en) 2003-09-09 2005-03-10 The Procter & Gamble Company Electric toothbrush comprising an electrically powered element
CA2556169C (en) * 2004-01-29 2011-11-22 Andrew Lees Use of amino-oxy functional groups in the preparation of vaccines
WO2007024852A2 (en) * 2005-08-22 2007-03-01 Biosynexus Incorporated Methods for testing vaccine candidates against bacterial infection in rodents
CA2881717C (en) * 2006-06-06 2018-06-12 Cecilia Anna Wilhelmina Geuijen Human binding molecules having killing activity against staphylococci and uses thereof
WO2009114520A2 (en) * 2008-03-10 2009-09-17 Pharmain Corporation Compositions for treatment with metallopeptidases, methods of making and using the same
EP2285831A4 (en) * 2008-05-07 2011-05-04 Innovative Biosensors Inc REAGENTS, METHODS, AND SYSTEMS FOR DETECTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS (MRSA)
CA2746330C (en) * 2008-12-23 2017-08-29 Genentech, Inc. Immunoglobulin variants with altered binding to protein a
WO2010085590A1 (en) * 2009-01-23 2010-07-29 Biosynexus Incorporated Opsonic and protective antibodies specific for lipoteichoic acid gram positive bacteria
MY192182A (en) * 2009-06-26 2022-08-04 Regeneron Pharma Readily isolated bispecific antibodies with native immunoglobulin format
WO2011017101A2 (en) 2009-07-27 2011-02-10 Fina Biosolutions, Llc Method for producing protein-carbohydrate vaccines reduced in free carbohydrate
CA2770771C (en) * 2009-08-10 2019-12-03 Fundacao Oswaldo Cruz Monoclonal antibodies for pbp2-a protein and homologous sequences for treatment of infections and immunodiagnosis on bacteria from phylum firmicutes
BR112012006107A2 (pt) 2009-09-17 2016-06-07 Eugene B Guthery formulações nasais, de ferida e de pele e métodos para controle de staphylococci e outras bactérias gram-positivas resistentes a antibiótico
CA2836153C (en) 2009-12-17 2016-06-21 Fina Biosolutions, Llc Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines
EP2560738B8 (en) 2010-04-23 2019-09-25 Serum Institute of India Private Limited Simple method for simultaneous removal of multiple impurities from culture supernatants to ultralow levels
US8387798B1 (en) 2012-04-27 2013-03-05 Abdulmohsen E. A. H. Al-Terki Mutiple oral and nasal surgical procedures method and kit
US10022083B2 (en) 2011-06-02 2018-07-17 Abdulmohsen E. A. H. Al-Terki Multiple oral and nasal surgical procedures method and kit
US10364298B2 (en) 2011-11-18 2019-07-30 National Research Council Of Canada Clostridium difficile lipoteichoic acid and uses thereof
US9988439B2 (en) 2011-12-23 2018-06-05 Nicholas B. Lydon Immunoglobulins and variants directed against pathogenic microbes
WO2013096948A1 (en) * 2011-12-23 2013-06-27 Lydon Nicholas B Immunoglobulins and variants directed against pathogenic microbes
US9777076B2 (en) 2012-07-16 2017-10-03 Pfizer Inc. Saccharides and uses thereof
US9434977B2 (en) * 2013-02-27 2016-09-06 Avent, Inc. Rapid identification of organisms in bodily fluids
JP6371758B2 (ja) 2013-03-12 2018-08-08 全薬工業株式会社 抗ブドウ球菌抗体、その製造方法並びにその使用
AR101262A1 (es) 2014-07-26 2016-12-07 Regeneron Pharma Plataforma de purificación para anticuerpos biespecíficos
CA3110377A1 (en) * 2018-11-21 2020-05-28 Regeneron Pharmaceuticals, Inc. Anti-staphylococcus antibodies and uses thereof
EP4228697A4 (en) * 2020-10-16 2025-01-01 Invisishield Technologies Ltd. Compositions for preventing or treating viral and other microbial infections
US20220280679A1 (en) * 2021-03-08 2022-09-08 Innovation Chemical and Enviromental Technologies, Inc. Prophylactic Gel Compositions and Use as Barriers to Bacterial and Viral Colonization
CA3256035A1 (en) 2022-04-14 2023-10-19 Invisishield Technologies Ltd. COMPOSITIONS FOR PREVENTING OR TREATMENT OF CORONAVIRUS INFECTIONS
WO2023201306A1 (en) 2022-04-14 2023-10-19 Invisishield Technologies Ltd. Compositions for preventing or treating influenza infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055455A (en) * 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US5681565A (en) * 1993-01-12 1997-10-28 Medical Sciences Research Institute Methods and compositions for passive immunotherapy
GB9416884D0 (en) * 1994-08-20 1994-10-12 Danbiosyst Uk Drug delivery compositions
JP3098401B2 (ja) * 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
WO2000071585A1 (en) * 1999-05-03 2000-11-30 Medarex, Inc. Human antibodies to staphylococcus aureus
US6197328B1 (en) * 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions

Similar Documents

Publication Publication Date Title
JP2005516044A5 (https=)
JP2006513139A5 (https=)
US12491245B2 (en) Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
US20100166772A1 (en) ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n
EP2464665B1 (en) Human monoclonal antibody against s. aureus derived alpha-toxin and its use in treating or preventing abscess formation
JP2005516044A (ja) モノクローナル抗体の鼻内投与によるブドウ球菌の鼻コロニー形成を阻止又は緩和する方法
JP2011521662A5 (https=)
JP2005519619A5 (https=)
CN102695724B (zh) 指向金黄葡萄球菌表位isaa或isab的抗体或其片段
KR20210126641A (ko) 보체 및 표적 항원에 결합하기 위해 이중 특이적 항체를 사용하는 조성물 및 방법
US10639370B2 (en) Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
JP2003531866A (ja) 抗体を用いた呼吸器疾患の組合せ治療法
EP4286409A1 (en) Antigen-binding protein targeting staphylococcus aureus ?-hemolysis and application thereof
CA2469714A1 (en) Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
JP2023548603A5 (https=)
US20250295870A1 (en) Compositions and methods for inhalable therapeutics
JP2025518050A (ja) 吸入可能治療薬のための組成物および方法
US20210340226A1 (en) Human medical prophylaxis of coronaviridae pathogenic infection by topical application of immune coronaviridae immunoglobulin a
Panina et al. Recombinant antibodies to the Ebola virus glycoprotein
CN104662042A (zh) 防止生物膜形成的方法
CN117679507A (zh) IgM抗体及其应用
AU2002365440A1 (en) Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
HK1237800A1 (en) Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
HK1237800B (zh) 可用於被动流感免疫的抗体及其组合物、组合和使用方法